Td Asset Management Inc Ionis Pharmaceuticals Inc Transaction History

Td Asset Management Inc

$107 Billion
Q3 2024

A detailed history of Td Asset Management Inc transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Td Asset Management Inc holds 1,092,990 shares of IONS stock, worth $39.9 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

1,092,990

Previous 952,762 14.72%

Holding current value

$39.9 Million

Previous $45.4 Million 3.57%

% of portfolio

0.04%

Previous 0.04%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	BUY	$40.06 - $51.86 $5.62 Million - $7.27 Million	140,228 Added 14.72%	1,092,990 $43.8 Million
Q2 2024 Aug 02, 2024	BUY	$36.45 - $47.7 $1.98 Million - $2.59 Million	54,400 Added 6.06%	952,762 $45.4 Million
Q1 2024 May 08, 2024	SELL	$42.03 - $53.55 $2.46 Million - $3.13 Million	-58,490 Reduced 6.11%	898,362 $38.9 Million
Q4 2023 Feb 12, 2024	BUY	$43.39 - $51.63 $2.52 Million - $2.99 Million	58,000 Added 6.45%	956,852 $48.4 Million
Q3 2023 Oct 27, 2023	BUY	$38.5 - $47.13 $4.38 Million - $5.36 Million	113,644 Added 14.47%	898,852 $40.8 Million
Q2 2023 Aug 09, 2023	SELL	$34.73 - $43.33 $1.11 Million - $1.39 Million	-32,100 Reduced 3.93%	785,208 $32.2 Million
Q1 2023 May 10, 2023	BUY	$33.58 - $41.2 $1.27 Million - $1.56 Million	37,813 Added 4.85%	817,308 $29.2 Million
Q4 2022 Feb 06, 2023	SELL	$37.12 - $46.52 $912,706 - $1.14 Million	-24,588 Reduced 3.06%	779,495 $29.4 Million
Q3 2022 Nov 07, 2022	BUY	$36.54 - $48.66 $15,310 - $20,388	419 Added 0.05%	804,083 $35.6 Million
Q2 2022 Aug 04, 2022	SELL	$31.71 - $43.0 $523,215 - $709,500	-16,500 Reduced 2.01%	803,664 $29.8 Million
Q1 2022 May 10, 2022	BUY	$29.88 - $37.04 $2.3 Million - $2.85 Million	77,000 Added 10.36%	820,164 $30.4 Million
Q4 2021 Feb 10, 2022	BUY	$25.61 - $35.1 $8.23 Million - $11.3 Million	321,200 Added 76.12%	743,164 $22.6 Million
Q3 2021 Nov 09, 2021	BUY	$33.54 - $40.55 $3,354 - $4,054	100 Added 0.02%	421,964 $14.2 Million
Q2 2021 Aug 11, 2021	SELL	$34.54 - $47.25 $93,776 - $128,283	-2,715 Reduced 0.64%	421,864 $15.7 Million
Q1 2021 May 14, 2021	BUY	$42.51 - $63.78 $1.67 Million - $2.5 Million	39,235 Added 10.18%	424,579 $19.1 Million
Q4 2020 Feb 16, 2021	BUY	$45.3 - $60.27 $4.79 Million - $6.37 Million	105,697 Added 37.8%	385,344 $21.8 Million
Q3 2020 Nov 10, 2020	BUY	$47.45 - $62.95 $3.45 Million - $4.57 Million	72,605 Added 35.07%	279,647 $13.3 Million
Q2 2020 Aug 13, 2020	BUY	$46.85 - $61.05 $5.21 Million - $6.79 Million	111,277 Added 116.2%	207,042 $12.2 Million
Q1 2020 May 15, 2020	BUY	$41.6 - $63.4 $2.24 Million - $3.41 Million	53,862 Added 128.54%	95,765 $4.53 Million
Q4 2019 Feb 11, 2020	SELL	$53.85 - $65.27 $280,020 - $339,404	-5,200 Reduced 11.04%	41,903 $2.53 Million
Q3 2019 Nov 07, 2019	SELL	$59.06 - $72.15 $94,496 - $115,440	-1,600 Reduced 3.29%	47,103 $2.82 Million
Q2 2019 Aug 01, 2019	SELL	$62.09 - $86.14 $1.41 Million - $1.96 Million	-22,700 Reduced 31.79%	48,703 $3.13 Million
Q1 2019 May 08, 2019	BUY	$52.92 - $81.17 $2.64 Million - $4.05 Million	49,900 Added 232.06%	71,403 $5.8 Million
Q4 2018 Feb 01, 2019	BUY	$43.37 - $59.54 $82,403 - $113,126	1,900 Added 9.69%	21,503 $1.16 Million
Q3 2018 Nov 01, 2018	SELL	$42.88 - $53.7 $85,760 - $107,400	-2,000 Reduced 9.26%	19,603 $1.01 Million
Q2 2018 Jul 31, 2018	SELL	$40.53 - $50.7 $20,265 - $25,350	-500 Reduced 2.26%	21,603 $900,000
Q1 2018 May 11, 2018	SELL	$44.08 - $55.05 $88,160 - $110,100	-2,000 Reduced 8.3%	22,103 $974,000
Q4 2017 Feb 02, 2018	BUY	$50.3 - $64.39 $316,890 - $405,657	6,300 Added 35.39%	24,103 $1.21 Million
Q3 2017 Nov 09, 2017	BUY	$45.56 - $59.57 $811,104 - $1.06 Million	17,803	17,803 $903,000

Others Institutions Holding IONS

# of Institutions

402

Shares Held

136M

Call Options Held

862K

Put Options Held

582K

View Full List

About IONIS PHARMACEUTICALS INC

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.19B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

More about IONS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.

Account

Td Asset Management Inc Ionis Pharmaceuticals Inc Transaction History